CVRdatabase
Menu

Unibio A/S

Public limited companyCVR 26110262RoskildeActive

Unibio A/S is a public limited company, based in Roskilde, active in research and experimental development on natural sciences and engineering, founded in 2001. The company made a loss in both 2024 and 2025, most recently DKK 66.4m. With 75 employees, the company is about 15 times larger than the industry median. Equity grew to DKK 192.9m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 23.3m+3,348.1% vs. 2024
Net profit−DKK 66.4m+30.7% vs. 2024
EquityDKK 192.9m+225.3% vs. 2024
Employees75latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 95.9m to DKK 66.4m (2024 → 2025).
  • Equity rose 225% (2024 → 2025), to DKK 192.9m.

Employees

  • 1 fewer employees than a year earlier: 75 (08/2026) against 76 (08/2025).

Management and owners, last 24 months

  • New in management: Neil Goldsmith (chair of the board, 01/10/2025).
  • Stepped down: Jan Boeg Hansen (chair of the board, 01/10/2025).

Registrations, last 24 months

  • 18/12/2025: Share capital changed from 10,750,000 DKK to 14,750,000 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 100m−DKK 50mDKK 0DKK 50mDKK 100mDKK 150mDKK 200m202020212022202320242025
EquityNet profit
Financial figures for Unibio A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−13,099−13,393−12,5581,344−71723,289+3,348.1%
Operating profit (EBIT)−44,732−48,391−58,489−78,011−104,337−72,172+30.8%
Profit before tax−47,152−47,533−54,825−76,548−101,407−71,922+29.1%
Net profit−41,743−41,849−49,325−78,336−95,907−66,422+30.7%
Total assets67,668118,87671,344174,89981,895206,422+152.1%
Equity24,705−17,14433,531155,19559,288192,866+225.3%
Liabilities42,963136,02037,81319,70422,60713,556−40%
Cash and cash equivalents15,83072,52726,196126,63635,503106,115+198.9%
Average number of employees334251586973+5.8%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Unibio A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202420/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202325/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202214/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202110/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202003/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405060708009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 23.3mNo. 51 of 421
Better than 88% of the companies in the industry
EquityDKK 192.9mNo. 21 of 431
Better than 95% of the companies in the industry
Number of employees75No. 28 of 431
Better than 94% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 3,097of 4,412
Better than 30%
No. 351of 4,466
Better than 92%
Same industry and 50–199 employees27 companies in the comparison
No. 21of 26
Better than 20%
No. 5of 27
Better than 85%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 2,961of 24,791
Better than 88%
No. 796of 24,909
Better than 97%
All companies of type A/S18,025 companies in the comparison
No. 5,311of 17,786
Better than 70%
No. 1,472of 18,024
Better than 92%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Unibio A/SDKK 23.3m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Unibio A/S−DKK 66.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Unibio A/SDKK 192.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Unibio A/S75
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Unibio International plc100%
Unibio A/S

Management

5 active registrations

Executive management

Executive management at Unibio A/S
NameRoleAppointed
David Richard HenstromCEO28/06/2021
Søren Olrik EklundDirector24/01/2024

Board of directors

Board of directors at Unibio A/S
NameRoleAppointed
Henrik Busch-LarsenBoard member29/05/2007
David Richard HenstromBoard member28/06/2021
Neil GoldsmithChair of the board01/10/2025
Founders
Preben Bang Henriksen. Aalborg ApS
Former management (21)
Former management at Unibio A/S
NameRoleAppointedResigned
Preben Bang HenriksenDirector01/07/200128/09/2001
Ebbe Bjerne Busch LarsenDirector28/09/200124/02/2012
Christen Jensen SørensenChair of the board15/11/200116/06/2014
Carl Bjarne MikkelsenBoard member15/11/200124/06/2004
Ebbe Bjerne Busch LarsenBoard member15/11/200116/06/2014
Johan ThomsenBoard member15/11/200116/06/2014
Sten Bay JørgensenBoard member25/05/200924/01/2024
Mogens Hønnerup NielsenBoard member29/01/201027/02/2012
Henrik Busch-LarsenDirector24/02/201229/05/2016
Keld FriisBoard member21/05/201221/03/2013
Leif KjærgaardBoard member16/06/201410/10/2014
Jens-Erik HinnerskovChair of the board16/06/201402/09/2014
Jeppe HøierBoard member10/10/201425/06/2021
Evert Harm HullemanChair of the board10/10/201418/11/2016
Jesper Halling PedersenDirector01/06/201501/05/2018
Leif JacobsenDirector01/04/201631/08/2017
Henrik Busch-LarsenCEO30/05/201631/05/2021
Jan Boeg HansenChair of the board18/11/201601/10/2025
Jakob Brix ChristensenDirector01/05/201831/05/2021
Jakob Brix ChristensenCEO01/06/202126/06/2021
Jakob Brix ChristensenDirector27/06/202124/01/2024

Signing rule: Selskabet tegnes af den administrerende direktør i forening med en anden direktør eller af formanden for bestyrelsen i forening med en direktør eller af formanden for bestyrelsen i forening med et andet bestyrelsesmedlem

Address and production units

2 active production units

Langebjerg 1
4000 Roskilde

Roskilde Municipality · Postcode 4000

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Unibio A/SAsnæsvej 2A, 4400 Kalundborg381022073571
UNIBIO A/SLangebjerg 1, 4000 Roskilde371008523645

Purpose

Selskabets formål er forskning, udvikling, produktion, fabrikation, handel og andet i forbindelse hermed beslægtet virksomhed efter selskabets skøn.

The purpose is quoted from the register in Danish.

Changes year by year

91 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20255 changescapital 1 · management 2 · accounts 1 · industry 1
  • Share capital changed from 10,750,000 DKK to 14,750,000 DKK
  • Neil Goldsmith appointed chair of the board
  • Jan Boeg Hansen stepped down as chair of the board
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20244 changesaccounts 1 · management 3
  • Annual report for 2023 published
  • Søren Olrik Eklund appointed director
  • Jakob Brix Christensen stepped down as director
  • Sten Bay Jørgensen stepped down as board member
20232 changescapital 1 · accounts 1
  • Share capital changed from 6,750,000 DKK to 10,750,000 DKK
  • Annual report for 2022 published
20222 changescapital 1 · accounts 1
  • Share capital changed from 4,750,000 DKK to 6,750,000 DKK
  • Annual report for 2021 published
202110 changesmanagement 8 · accounts 1 · address 1
  • David Richard Henstrom appointed ceo
  • David Richard Henstrom appointed board member
  • Jakob Brix Christensen appointed director
  • Jakob Brix Christensen stepped down as ceo
  • Jeppe Høier stepped down as board member
  • Annual report for 2020 published
  • Jakob Brix Christensen appointed ceo
  • Jakob Brix Christensen stepped down as director
  • Henrik Busch-Larsen stepped down as ceo
  • Moved to Langebjerg 1, 4000 Roskilde
20193 changescapital 1 · address 2
  • Share capital changed from 3,136,845 DKK to 4,750,000 DKK
  • Moved to Langebjerg 1, 4000 Roskilde
  • Moved to Niels Bohrs Allé 17, 5230 Odense M
20185 changescapital 1 · address 2 · management 2
  • Share capital changed from 2,715,792 DKK to 3,136,845 DKK
  • Moved to Niels Bohrs Allé 17, 5230 Odense M
  • Moved to Niels Bohrs Allé 17, 5230 Odense M
  • Jakob Brix Christensen appointed director
  • Jesper Halling Pedersen stepped down as director
20173 changescapital 2 · management 1
  • Share capital changed from 2,568,423 DKK to 2,715,792 DKK
  • Leif Jacobsen stepped down as director
  • Share capital changed from 2,421,054 DKK to 2,568,423 DKK
201610 changescapital 2 · address 1 · management 5 · ownership 2
  • Share capital changed from 2,273,685 DKK to 2,421,054 DKK
  • Moved to Niels Bohrs Allé 17, 5230 Odense M
  • Jan Boeg Hansen appointed chair of the board
  • Evert Harm Hulleman stepped down as chair of the board
  • Unibio International plc registered as owner (100%)
  • Unibio International plc is no longer registered as owner
  • Henrik Busch-Larsen appointed ceo
  • Henrik Busch-Larsen stepped down as director
  • Leif Jacobsen appointed director
  • Share capital changed from 2,147,369 DKK to 2,273,685 DKK
20154 changescapital 2 · management 1 · ownership 1
  • Share capital changed from 2,084,211 DKK to 2,147,369 DKK
  • Jesper Halling Pedersen appointed director
  • Share capital changed from 2,000,000 DKK to 2,084,211 DKK
  • Unibio International plc registered as owner (100%)
201411 changesmanagement 9 · capital 2
  • Evert Harm Hulleman appointed chair of the board
  • Jeppe Høier appointed board member
  • Leif Kjærgaard stepped down as board member
  • Share capital changed from 1,875,000 DKK to 2,000,000 DKK
  • Share capital changed from 1,566,668 DKK to 1,875,000 DKK
  • Jens-Erik Hinnerskov stepped down as chair of the board
  • Leif Kjærgaard appointed board member
  • Jens-Erik Hinnerskov appointed chair of the board
  • Johan Thomsen stepped down as board member
  • Ebbe Bjerne Busch Larsen stepped down as board member
  • Christen Jensen Sørensen stepped down as chair of the board
20132 changescapital 1 · management 1
  • Share capital changed from 1,424,286 DKK to 1,566,668 DKK
  • Keld Friis stepped down as board member
20126 changesmanagement 4 · capital 2
  • Keld Friis appointed board member
  • Share capital changed from 1,281,879 DKK to 1,424,286 DKK
  • Mogens Hønnerup Nielsen stepped down as board member
  • Share capital changed from 1,092,000 DKK to 1,281,879 DKK
  • Henrik Busch-Larsen appointed director
  • Ebbe Bjerne Busch Larsen stepped down as director
20111 changeaddress 1
  • Moved to Billedskærervej 8, 5230 Odense M
20102 changescapital 1 · management 1
  • Share capital changed from 555,500 DKK to 1,092,000 DKK
  • Mogens Hønnerup Nielsen appointed board member
20091 changemanagement 1
  • Sten Bay Jørgensen appointed board member
20081 changeindustry 1
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20073 changesmanagement 1 · name 1 · capital 1
  • Henrik Busch-Larsen appointed board member
  • Name changed from UNIBIO HOLDING A/S to UNIBIO A/S
  • Share capital changed from 500,000 DKK to 555,500 DKK
20041 changemanagement 1
  • Carl Bjarne Mikkelsen stepped down as board member
200114 changesindustry 1 · name 2 · capital 1 · management 7 · address 2 · founded 1
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Name changed from UNIBIO HOLDING ApS to UNIBIO HOLDING A/S
  • Share capital changed from 125,000 DKK to 500,000 DKK
  • Carl Bjarne Mikkelsen appointed board member
  • Johan Thomsen appointed board member
  • Ebbe Bjerne Busch Larsen appointed board member
  • Christen Jensen Sørensen appointed chair of the board
  • Name changed from PBH 27.792 ApS to UNIBIO HOLDING ApS
  • Moved to Slagkrogen 15, 5220 Odense SØ
  • Moved to Nørregade 73, 5000 Odense C
  • Ebbe Bjerne Busch Larsen appointed director
  • Preben Bang Henriksen stepped down as director
  • Registered as PBH 27.792 ApS
  • Preben Bang Henriksen appointed director

Related companies

Same industry in Roskilde

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction